The Post-COVID Supply Chain
Summary: During this panel discussion, executives share how their companies adapted to the challenges and what lessons they will take forward to ensure…
Catalent’s Chair and CEO Shares His Views About Drug Development and Manufacturing in a Pandemic
Summary: In December 2021, John Chiminski was featured on the expert panel of STAT’s “A Look Ahead at Biotech in 2022” event, which focused on the ongoing battle against the SARS-CoV-2 virus and explored what might be in store for the biotech industry in the years to come.
mRNA-A 20 Year Voyage to Patients
Summary: On December 13, 2021, EuropaBio hosted the final event of its 25th Anniversary programme with a focus on the story of mRNA.
The New Normal: How the Supply Chain has Been Impacted by COVID-19
Summary: Supply chains have come under intense pressure, and companies have had to adapt to this “new normal” to avoid delays. During this Q&A, Catalent discusses….
Women in BioPharma Awards 2021
Summary: Join us as we honor a group of 20 extraordinary women who are making lasting impacts in the drug development field.
Strategies to Accelerate the Path to Clinic for Next-Generation Antibodies
Summary: Experts discuss formulation development and purification strategies to increase throughput, reduce operating costs and decrease…